Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hemolife Medical is a specialized medical technology company focused on the development and manufacturing of extracorporeal blood purification products. Headquartered in Suzhou, China, the company provides a comprehensive portfolio of hemoperfusion cartridges, hemodialyzers, and integrated blood purification systems. Their core technology utilizes advanced adsorption resins designed to selectively remove inflammatory cytokines, metabolic toxins, and poisons from the bloodstream. These solutions are primarily indicated for patients suffering from end-stage renal disease, sepsis, acute liver failure, and severe intoxication. Hemolife aims to improve clinical outcomes in critical care and nephrology through innovative filtration and adsorption medical device technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hemolife Medical.